Live Breaking News & Updates on Oetis

Stay informed with the latest breaking news from Oetis on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Oetis and stay connected to the pulse of your community

Phibro snaps up Zoetis' medicated feed portfolio for $350M

Phibro Animal Health is to acquire Zoetis’ medicated feed additive (MFA) product portfolio focused on cattle, swine, and poultry production, along with certain water-soluble products and related assets for US$350m.

China , Italy , United-states , America , Glenn-david , Larry-miller , Phibro-animal-health , North-america , Suppliers , Attle-beef , Wine , Oultry

INVESTIGATION ALERT: The Schall Law Firm Announces it is

The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm...

Brian-schall , Los-angeles , Schall-law-firm , Zoetis-inc , Business-daily , Wall-street-journal , Park-east , Attorney-advertising , Schall-law , Ts , Oetis , Lass-action

EU targets Zoetis in antitrust investigation over dog medicines

(Reuters) -EU antitrust regulators have started an investigation into whether Zoetis blocked the market launch of a rival pain medicine for dogs, the European Commission said on Tuesday, a move that could result in a hefty fine for the U.S. pet products maker. Antitrust regulators on both sides of the Atlantic have recently cracked down on Big Tech and Big Pharma acquiring start-ups or small rivals in order to shut them down in what is known as killer acquisitions. Zoetis' Librela is currently the first and only monoclonal antibody medicine approved in Europe to treat pain associated with osteoarthritis in dogs.

Bart-meijer , Reuters , European-commission-on , European-commission , Oetis , Ntitrust-regulators , Ntitrust-rules ,

1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now

Buoyed by megatrends in animal healthcare, this stock makes for an excellent holding in almost any portfolio.

Motley-fool-stock-advisor , Stock-advisor , Return-on-invested-capital , Oetis , Ividend-payments ,

A Look At The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Key Insights The projected fair value for Zoetis is US$204 based on 2 Stage Free Cash Flow to Equity With US$188 share...

United-states , American , Solid-businesses , Discounted-cash-flow , Uture-cash-flows , Ree-cash-flow , Oetis , Erminal-value , Hare-price , Air-value ,

Zoetis Inc (ZTS) Reports Solid Growth in Q4 and Full Year 2023 Earnings

Zoetis Achieves Revenue and Net Income Growth, Provides Optimistic 2024 Guidance

New-zealand , China , Australia , Kristin-peck , Zoetis-inc , Financial-performance , Per-share , Chief-executive-officer , Revenue-growth , Oetis , Et-income , Djusted-basis

Zoetis (ZTS) Q4 2023 Earnings Call Transcript

ZTS earnings call for the period ending December 31, 2023.

Utah , United-states , Australia , Brazil , China , Mexico , Argentina , Turkey , Balaji-prasad-barclays , Chris-schott , Michael-ryskin , Stephen-scala

4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either

These stocks never seem to go on sale. Here's why I'm buying them anyway.

Pfizer , Motley-fool-stock-advisor , Stock-advisor , Cintas , Nergy-drinks , Oetis , Ollins ,

Calculating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Key Insights The projected fair value for Zoetis is US$176 based on 2 Stage Free Cash Flow to Equity Zoetis' US$197...

United-states , American , Solid-businesses , Discounted-cash-flow , Uture-cash-flows , Ree-cash-flow , Resent-value , Oetis , Rowth-rate , Ts , Oetis-inc-

Is Zoetis (NYSE:ZTS) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

How-healthy-is-zoeti-balance , Free-cash-flow , Alance-sheet , Oetis , Bit , Iabilities ,